Daiichi Sankyo to Strengthen Cardiovascular Field by Comarketing Diabetes Treatments, Focusing on SGLT-2 Inhibitor

Ryoichi Kibushi, Head of Sales & Marketing Division, Daiichi Sankyo Daiichi Sankyo intends to enhance its product portfolios in the cardiovascular field by comarketing two diabetes treatments from Mitsubishi Tanabe Pharma Corporation (MTPC) and to strengthen its business base for...read more